GENE ONLINE|News &
Marvin White Steps Down as Aptevo CEO, Alexander Wu Named Interim Replacement
Aptevo Therapeutics announced changes to its executive leadership team as part of its strategy to support the company’s next phase of growth. The company revealed that Marvin White, who has served as Chief Executive Officer since 2016, will step down from his position. Alexander Wu, a member of Aptevo’s Board of Directors, will assume the role of Interim CEO while the company conducts a search for a permanent replacement.
The announcement also included details about additional leadership adjustments. In conjunction with White’s departure, Aptevo stated that it remains committed to advancing its pipeline and strategic initiatives during this transition period. The company emphasized that these changes aim to align leadership with its long-term goals and operational priorities. Further updates regarding the CEO search process and other organizational developments are expected in the coming months.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: February 3, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Researchers at Nanjing University Induce Nonlinear Hall Effect in MoS2 Thin Flakes Using Electrochemical Intercalation Technique
2026-02-09
Machine Learning Method Developed by Chinese Researchers Analyzes Secondary Structures of Nucleic Acid Aptamers
2026-02-09
